Global Peripheral Chronic Total Occlusion Device Market Growth 2025-2031

Publication ID:

LPI03258635

Publication Date:

March 28, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Peripheral Chronic Total Occlusion Device market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Peripheral Chronic Total Occlusion Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Peripheral Chronic Total Occlusion Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Peripheral Chronic Total Occlusion Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Peripheral Chronic Total Occlusion Device players cover Medtronic Plc, Boston Scientific Corporation, Avinger, Inc., Cardinal Health, Koninklijke Philips N.V., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淧eripheral Chronic Total Occlusion Device Industry Forecast鈥� looks at past sales and reviews total world Peripheral Chronic Total Occlusion Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Peripheral Chronic Total Occlusion Device sales for 2025 through 2031. With Peripheral Chronic Total Occlusion Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peripheral Chronic Total Occlusion Device industry.
This Insight Report provides a comprehensive analysis of the global Peripheral Chronic Total Occlusion Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peripheral Chronic Total Occlusion Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Peripheral Chronic Total Occlusion Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peripheral Chronic Total Occlusion Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peripheral Chronic Total Occlusion Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Peripheral Chronic Total Occlusion Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Micro Catheters
Guide Wires
Crossing Devices
Re-entry Devices
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic Plc
Boston Scientific Corporation
Avinger, Inc.
Cardinal Health
Koninklijke Philips N.V.
Cook Medical Incorporated
C.R. Bard
Baylis Medical Company
BTG Vascular
Soundbite Medical Solutions
Key Questions Addressed in this Report
What is the 10-year outlook for the global Peripheral Chronic Total Occlusion Device market?
What factors are driving Peripheral Chronic Total Occlusion Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Peripheral Chronic Total Occlusion Device market opportunities vary by end market size?
How does Peripheral Chronic Total Occlusion Device break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Peripheral Chronic Total Occlusion Device Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Peripheral Chronic Total Occlusion Device by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Peripheral Chronic Total Occlusion Device by Country/Region, 2020, 2024 & 2031
2.2 Peripheral Chronic Total Occlusion Device Segment by Type
2.2.1 Micro Catheters
2.2.2 Guide Wires
2.2.3 Crossing Devices
2.2.4 Re-entry Devices
2.3 Peripheral Chronic Total Occlusion Device Sales by Type
2.3.1 Global Peripheral Chronic Total Occlusion Device Sales Market Share by Type (2020-2025)
2.3.2 Global Peripheral Chronic Total Occlusion Device Revenue and Market Share by Type (2020-2025)
2.3.3 Global Peripheral Chronic Total Occlusion Device Sale Price by Type (2020-2025)
2.4 Peripheral Chronic Total Occlusion Device Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Peripheral Chronic Total Occlusion Device Sales by Application
2.5.1 Global Peripheral Chronic Total Occlusion Device Sale Market Share by Application (2020-2025)
2.5.2 Global Peripheral Chronic Total Occlusion Device Revenue and Market Share by Application (2020-2025)
2.5.3 Global Peripheral Chronic Total Occlusion Device Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Peripheral Chronic Total Occlusion Device Breakdown Data by Company
3.1.1 Global Peripheral Chronic Total Occlusion Device Annual Sales by Company (2020-2025)
3.1.2 Global Peripheral Chronic Total Occlusion Device Sales Market Share by Company (2020-2025)
3.2 Global Peripheral Chronic Total Occlusion Device Annual Revenue by Company (2020-2025)
3.2.1 Global Peripheral Chronic Total Occlusion Device Revenue by Company (2020-2025)
3.2.2 Global Peripheral Chronic Total Occlusion Device Revenue Market Share by Company (2020-2025)
3.3 Global Peripheral Chronic Total Occlusion Device Sale Price by Company
3.4 Key Manufacturers Peripheral Chronic Total Occlusion Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peripheral Chronic Total Occlusion Device Product Location Distribution
3.4.2 Players Peripheral Chronic Total Occlusion Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Peripheral Chronic Total Occlusion Device by Geographic Region
4.1 World Historic Peripheral Chronic Total Occlusion Device Market Size by Geographic Region (2020-2025)
4.1.1 Global Peripheral Chronic Total Occlusion Device Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Peripheral Chronic Total Occlusion Device Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Peripheral Chronic Total Occlusion Device Market Size by Country/Region (2020-2025)
4.2.1 Global Peripheral Chronic Total Occlusion Device Annual Sales by Country/Region (2020-2025)
4.2.2 Global Peripheral Chronic Total Occlusion Device Annual Revenue by Country/Region (2020-2025)
4.3 Americas Peripheral Chronic Total Occlusion Device Sales Growth
4.4 APAC Peripheral Chronic Total Occlusion Device Sales Growth
4.5 Europe Peripheral Chronic Total Occlusion Device Sales Growth
4.6 Middle East & Africa Peripheral Chronic Total Occlusion Device Sales Growth
5 Americas
5.1 Americas Peripheral Chronic Total Occlusion Device Sales by Country
5.1.1 Americas Peripheral Chronic Total Occlusion Device Sales by Country (2020-2025)
5.1.2 Americas Peripheral Chronic Total Occlusion Device Revenue by Country (2020-2025)
5.2 Americas Peripheral Chronic Total Occlusion Device Sales by Type (2020-2025)
5.3 Americas Peripheral Chronic Total Occlusion Device Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peripheral Chronic Total Occlusion Device Sales by Region
6.1.1 APAC Peripheral Chronic Total Occlusion Device Sales by Region (2020-2025)
6.1.2 APAC Peripheral Chronic Total Occlusion Device Revenue by Region (2020-2025)
6.2 APAC Peripheral Chronic Total Occlusion Device Sales by Type (2020-2025)
6.3 APAC Peripheral Chronic Total Occlusion Device Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Peripheral Chronic Total Occlusion Device by Country
7.1.1 Europe Peripheral Chronic Total Occlusion Device Sales by Country (2020-2025)
7.1.2 Europe Peripheral Chronic Total Occlusion Device Revenue by Country (2020-2025)
7.2 Europe Peripheral Chronic Total Occlusion Device Sales by Type (2020-2025)
7.3 Europe Peripheral Chronic Total Occlusion Device Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Peripheral Chronic Total Occlusion Device by Country
8.1.1 Middle East & Africa Peripheral Chronic Total Occlusion Device Sales by Country (2020-2025)
8.1.2 Middle East & Africa Peripheral Chronic Total Occlusion Device Revenue by Country (2020-2025)
8.2 Middle East & Africa Peripheral Chronic Total Occlusion Device Sales by Type (2020-2025)
8.3 Middle East & Africa Peripheral Chronic Total Occlusion Device Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Peripheral Chronic Total Occlusion Device
10.3 Manufacturing Process Analysis of Peripheral Chronic Total Occlusion Device
10.4 Industry Chain Structure of Peripheral Chronic Total Occlusion Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Peripheral Chronic Total Occlusion Device Distributors
11.3 Peripheral Chronic Total Occlusion Device Customer
12 World Forecast Review for Peripheral Chronic Total Occlusion Device by Geographic Region
12.1 Global Peripheral Chronic Total Occlusion Device Market Size Forecast by Region
12.1.1 Global Peripheral Chronic Total Occlusion Device Forecast by Region (2026-2031)
12.1.2 Global Peripheral Chronic Total Occlusion Device Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Peripheral Chronic Total Occlusion Device Forecast by Type (2026-2031)
12.7 Global Peripheral Chronic Total Occlusion Device Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Medtronic Plc
13.1.1 Medtronic Plc Company Information
13.1.2 Medtronic Plc Peripheral Chronic Total Occlusion Device Product Portfolios and Specifications
13.1.3 Medtronic Plc Peripheral Chronic Total Occlusion Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Medtronic Plc Main Business Overview
13.1.5 Medtronic Plc Latest Developments
13.2 Boston Scientific Corporation
13.2.1 Boston Scientific Corporation Company Information
13.2.2 Boston Scientific Corporation Peripheral Chronic Total Occlusion Device Product Portfolios and Specifications
13.2.3 Boston Scientific Corporation Peripheral Chronic Total Occlusion Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Boston Scientific Corporation Main Business Overview
13.2.5 Boston Scientific Corporation Latest Developments
13.3 Avinger, Inc.
13.3.1 Avinger, Inc. Company Information
13.3.2 Avinger, Inc. Peripheral Chronic Total Occlusion Device Product Portfolios and Specifications
13.3.3 Avinger, Inc. Peripheral Chronic Total Occlusion Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Avinger, Inc. Main Business Overview
13.3.5 Avinger, Inc. Latest Developments
13.4 Cardinal Health
13.4.1 Cardinal Health Company Information
13.4.2 Cardinal Health Peripheral Chronic Total Occlusion Device Product Portfolios and Specifications
13.4.3 Cardinal Health Peripheral Chronic Total Occlusion Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Cardinal Health Main Business Overview
13.4.5 Cardinal Health Latest Developments
13.5 Koninklijke Philips N.V.
13.5.1 Koninklijke Philips N.V. Company Information
13.5.2 Koninklijke Philips N.V. Peripheral Chronic Total Occlusion Device Product Portfolios and Specifications
13.5.3 Koninklijke Philips N.V. Peripheral Chronic Total Occlusion Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Koninklijke Philips N.V. Main Business Overview
13.5.5 Koninklijke Philips N.V. Latest Developments
13.6 Cook Medical Incorporated
13.6.1 Cook Medical Incorporated Company Information
13.6.2 Cook Medical Incorporated Peripheral Chronic Total Occlusion Device Product Portfolios and Specifications
13.6.3 Cook Medical Incorporated Peripheral Chronic Total Occlusion Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Cook Medical Incorporated Main Business Overview
13.6.5 Cook Medical Incorporated Latest Developments
13.7 C.R. Bard
13.7.1 C.R. Bard Company Information
13.7.2 C.R. Bard Peripheral Chronic Total Occlusion Device Product Portfolios and Specifications
13.7.3 C.R. Bard Peripheral Chronic Total Occlusion Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 C.R. Bard Main Business Overview
13.7.5 C.R. Bard Latest Developments
13.8 Baylis Medical Company
13.8.1 Baylis Medical Company Company Information
13.8.2 Baylis Medical Company Peripheral Chronic Total Occlusion Device Product Portfolios and Specifications
13.8.3 Baylis Medical Company Peripheral Chronic Total Occlusion Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Baylis Medical Company Main Business Overview
13.8.5 Baylis Medical Company Latest Developments
13.9 BTG Vascular
13.9.1 BTG Vascular Company Information
13.9.2 BTG Vascular Peripheral Chronic Total Occlusion Device Product Portfolios and Specifications
13.9.3 BTG Vascular Peripheral Chronic Total Occlusion Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 BTG Vascular Main Business Overview
13.9.5 BTG Vascular Latest Developments
13.10 Soundbite Medical Solutions
13.10.1 Soundbite Medical Solutions Company Information
13.10.2 Soundbite Medical Solutions Peripheral Chronic Total Occlusion Device Product Portfolios and Specifications
13.10.3 Soundbite Medical Solutions Peripheral Chronic Total Occlusion Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Soundbite Medical Solutions Main Business Overview
13.10.5 Soundbite Medical Solutions Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂